(NASDAQ: APYX) Apyx Medical's forecast annual revenue growth rate of 14.41% is forecast to beat the US Medical Devices industry's average forecast revenue growth rate of 9.72%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 22.74%.
Apyx Medical's revenue in 2025 is $47,902,000.On average, 7 Wall Street analysts forecast APYX's revenue for 2026 to be $2,133,898,299, with the lowest APYX revenue forecast at $1,972,173,283, and the highest APYX revenue forecast at $2,328,932,015. On average, 4 Wall Street analysts forecast APYX's revenue for 2027 to be $2,285,795,146, with the lowest APYX revenue forecast at $2,196,156,120, and the highest APYX revenue forecast at $2,353,024,415.
In 2028, APYX is forecast to generate $2,832,654,387 in revenue, with the lowest revenue forecast at $2,721,599,895 and the highest revenue forecast at $2,915,983,498.